Inventor · name-matched record
BELL ANDREW SIMON
2 granted patents·4 pending applications·0 citations·filing 2022–2025
24Inventor score
Files withMYRICX PHARMA LTD2HOFFMANN LA ROCHE1RE VENTURES I LLC1RECURSION PHARMACEUTICALS INC1SUMITOMO PHARMA CO LTD1
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
6 records- 0183US2026078115A1Aliphatic acid amide derivativeSUMITOMO PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 0272US2026083858A1Antibody drug conjugate comprising nmt inhibitor and its useMYRICX PHARMA LTD·Filed 2023·Application pending·0 cites
- 0367US12533356B2Pyrazolopyrimidine compounds as adenosine receptor antagonistsRECURSION PHARMACEUTICALS INC·Filed 2023·Granted Jan 27, 2026·0 cites·12 claims
- 0461US2026049075A1Cytotoxic imidazo[1,2-a]pyridine compounds and their use in therapyMYRICX PHARMA LTD·Filed 2025·Application pending·0 cites
- 0556US12565497B2Sulfone derivativesHOFFMANN LA ROCHE·Filed 2022·Granted Mar 3, 2026·0 cites·36 claims
- 0642US2026001886A1Enpp1 inhibitors iRE VENTURES I LLC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BELL ANDREW SIMON files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →